Akums Drugs & Pharmaceuticals has signed a long-term contract worth Rs 1760 crore with an unnamed global pharmaceutical company to manufacture and supply oral liquid formulations in Europe. They will receive an upfront payment of €100 million and expect commercial supply from 2027 to 2032. Approval processes are anticipated to be completed by 2026.
